FDA Inspection 1033805 — Abbott Diabetes Care, Inc.

Abbott Diabetes Care, Inc. — FEI 3002803444

The FDA completed an inspection of Abbott Diabetes Care, Inc. on Dec 4, 2017 in Alameda, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Dec 4, 2017
Fiscal Year
2018
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Alameda, CA (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.